Grants for State governments - Education

This grant provides financial support for summer research programs designed to engage high school and undergraduate students, as well as science teachers, in hands-on biomedical and behavioral research experiences to inspire future careers in these fields.

This funding opportunity supports research on how diet and lipid metabolism influence tumor growth and progression, targeting higher education institutions, nonprofits, and certain for-profit organizations with expertise in nutrition science.

This funding opportunity supports researchers at higher education institutions and nonprofits to explore how dietary fats influence cancer growth and progression through molecular mechanisms, with a focus on preclinical studies.

This funding opportunity provides financial support for small-scale research projects that aim to improve the adoption and sustainability of evidence-based health practices, particularly in underserved communities, by addressing barriers and engaging diverse stakeholders.

This funding opportunity supports U.S.-based researchers and institutions in developing innovative computational methods for automating the curation of large biomedical datasets to improve data accessibility and quality for scientific research.

This funding opportunity supports research projects that improve the implementation and sustainability of evidence-based health interventions, particularly in underserved communities, by encouraging diverse perspectives and addressing barriers to effective healthcare practices.

This funding opportunity supports research on how inflammasome activation affects neurocognitive disorders and immune function in individuals with HIV and substance use disorders, encouraging studies that explore the interactions between these factors.

This funding opportunity provides financial support for research on the role of inflammasomes in the brain related to HIV and substance use disorders, targeting innovative studies that explore their impact on inflammation and neurocognitive health.

This funding opportunity supports research projects aimed at improving the management of multiple chronic diseases in low- and middle-income countries and American Indian/Alaska Native populations in the U.S. through innovative, community-centered healthcare strategies.

This grant provides funding for research projects that explore the complex processes of cancer metastasis, encouraging collaboration among institutions to improve understanding and treatment of metastatic diseases.

This funding opportunity supports U.S. educational institutions and organizations in developing group projects abroad that focus on modern foreign languages and area studies, particularly for less commonly taught languages, benefiting faculty, teachers, and students.

This grant provides funding for researchers and organizations to develop innovative medical countermeasures for treating acute chemical exposures resulting from terrorist attacks or accidental releases, enhancing national preparedness for chemical emergencies.

This grant provides funding for U.S. educational institutions and organizations to support short-term projects that promote less commonly taught foreign languages and area studies through international seminars, curriculum development, or research abroad.

This funding opportunity supports multidisciplinary research and community projects aimed at reducing health disparities related to environmental factors among disadvantaged populations in the U.S.

This funding opportunity provides financial support for small-scale cancer research projects that can be completed quickly, targeting a wide range of organizations, including universities, nonprofits, and businesses, to advance cancer prevention, diagnosis, and treatment.

The National Institutes of Health (NIH) has announced a funding opportunity titled Co-infection and Cancer (R01 Clinical Trial Not Allowed) under Funding Opportunity Number PAR-25-082. This initiative, led by the National Cancer Institute (NCI), is aimed at advancing research into the roles of co-infection in cancer development and progression. Co-infection is defined as the occurrence of two or more infections, whether simultaneous or sequential, involving pathogens or non-pathogenic agents, including viruses, bacteria, and parasites. The goal of this program is to explore how these co-infections contribute to cancer risk and progression and identify potential strategies for cancer prevention and treatment. The program encourages investigations that focus on co-infections with known oncogenic agents, excluding human immunodeficiency virus (HIV), and seeks studies that can lead to new opportunities in cancer treatment and prevention. In addition to pathogenic agents, research that includes the role of non-pathogenic agents, such as those in the microbiome, will be considered responsive. The program supports projects that delve into uncharted areas of co-infection and cancer, with an emphasis on mechanistic and epidemiologic research that could have practical implications for cancer control. Applicants are encouraged to focus on differences in cancer susceptibility, progression, and survival among diverse populations, including those that are racially or ethnically diverse, as well as medically underserved communities. International collaborations are also supported, particularly for studies in low- and middle-income countries where infection-associated cancers are more prevalent. The first submission date is January 5, 2025, with application due dates beginning on February 5, 2025. Budgets are not limited but must align with the scope of the project, and the maximum project period is five years. Applications must be submitted electronically through NIH's ASSIST system or Grants.gov. Eligible applicants include higher education institutions, nonprofits, for-profit organizations, and foreign entities. The program seeks to support well-developed research projects backed by preliminary data. Studies that focus solely on co-infection with HIV or involve only a single pathogen will not be considered responsive. Evaluation criteria include the scientific merit of the project, innovation, and feasibility, as well as the expertise of the research team. This funding opportunity offers a unique chance to explore how co-infections contribute to cancer and potentially uncover new strategies for prevention and treatment across diverse populations.

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed) aims to support the clinical validation of already analytically validated biomarkers and assays for cancer detection, diagnosis, and treatment monitoring, ensuring they are reliable and ready for use in clinical studies without conducting new trials.

Assay Validation of High Quality Markers for Clinical Studies in Cancer aims to fund the validation of reliable molecular, cellular, or imaging markers for cancer detection, diagnosis, and treatment, ensuring they meet necessary performance standards for use in clinical trials and studies.

Grant Title: Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 Clinical Trial Optional) aims to support the development and testing of integrated healthcare models that combine HIV/AIDS, Hepatitis, addiction treatment, and primary care services to improve health outcomes for individuals at risk for or living with these conditions.

Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services aims to fund research that develops and tests innovative models of integrated healthcare to improve outcomes for individuals at high risk for or living with HIV, Hepatitis, and substance use disorders by enhancing service delivery and coordination of care.